1 min read

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

stent-403500-edited.png

“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."

The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients.  The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here

LEARN ABOUT PULSARA

Case Study: St. Bernards Medical Center Improves Stroke DTN Times by 48%

Case Study: St. Bernards Medical Center Improves Stroke DTN Times by 48%

How an Arkansas hospital improved their door-to-needle benchmark success rates across the board and achieved a record treatment time of 18 minutes. ...

Read More >>
The Impact of Policy & Procedure on Fire Command

The Impact of Policy & Procedure on Fire Command

Editor's Note: In May 2025, FireRescue1 released their annual digital edition, Fire Command Ready: Building Bench Strength, proudly sponsored by...

Read More >>
CommonSpirit Mercy Hospital Improves Rural Cardiac Care with Pulsara (AHA Podcast Interview)

CommonSpirit Mercy Hospital Improves Rural Cardiac Care with Pulsara (AHA Podcast Interview)

On August 15th, 2025, the American Hospital Association released an episode of their Advancing Health Podcast in which they interviewed Josh Neff,...

Read More >>